AstraZeneca | Валовая Прибыль



Gross Profit On Sales Изменить Дата
AbbVie USD 10.71B 458M 2024-12
Alcon AG USD 1.38B 14M 2024-12
Almirall EUR 231.69M 73.09M 2024-06
Amgen USD 5.97B 781M 2024-12
argenx SE USD 665.76M 371.88M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Autolus Therapeutics Ltd -11358000 11.24M 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Fresenius EUR 1.42B 52M 2024-12
Fresenius Medical Care EUR 1.27B 124.43M 2024-12
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 6.1B 837M 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
GRIFOLS EUR 766.49M 39.74M 2024-12
Haleon 1.53B 220M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Indivior 222M 54M 2025-03
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Orion EUR 201.8M 65.5M 2025-03
Pfizer USD 11.12B 987M 2025-03
Philips EUR 1.96B 43M 2024-12
Recordati EUR 385.12M 1.11M 2024-09
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
UCB EUR 970M 788M 2024-06



AstraZeneca Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.